Approach for detecting mutagenicity of biodegraded and ozonated pharmaceuticals, metabolites and transformation products from a drinking water perspective

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Environmental science and pollution research international

• Publication date

  2012-05-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s11356-012-0925-xPMID 22547254
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drinking Water Toxicology in Its Regulatory Framework

  2011cited by this paper
• Treatise on water science

  2011cited by this paper
• Incomplete aerobic degradation of the antidiabetic drug Metformin and identification of the bacterial dead-end transformation product Guanylurea.

  2011cited by this paper
• Impact of ozonation on the genotoxic activity of tertiary treated municipal wastewater.

  2011cited by this paper
• Comparative toxicity assessment of ozone and activated carbon treated sewage effluents using an in vivo test battery.

  2010cited by this paper
• Formation, Detection and Removal of NDMA in Water Treatment Process

  2010cited by this paper
• A tiered procedure for assessing the formation of biotransformation products of pharmaceuticals and biocides during activated sludge treatment.

  2010cited by this paper
• Kinetics and mechanisms of N-nitrosodimethylamine formation upon ozonation of N,N-dimethylsulfamide-containing waters: bromide catalysis.

  2010cited by this paper
• Elimination of organic micropollutants in a municipal wastewater treatment plant upgraded with a full-scale post-ozonation followed by sand filtration.

  2009cited by this paper
• Ozonation of metoprolol: elucidation of oxidation pathways and major oxidation products.

  2009cited by this paper
• Ozone oxidation of pharmaceuticals, endocrine disruptors and pesticides during drinking water treatment.

  2009cited by this paper
• The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters.

  2009cited by this paper
• Ozonation of propranolol: formation of oxidation products.

  2009cited by this paper
• Removal of pharmaceutical compounds, nitroimidazoles, from waters by using the ozone/carbon system.

  2008cited by this paper
• Oxidative transformations of environmental pharmaceuticals by Cl₂, ClO₂, O₃, and Fe(VI): kinetics assessment.

  2008cited by this paper
• Behaviour and redox sensitivity of pharmaceutical residues during bank filtration - Investigation of residues of phenazone-type analgesics.

  2008cited by this paper
• N,N-dimethylsulfamide as precursor for N-nitrosodimethylamine (NDMA) formation upon ozonation and its fate during drinking water treatment.

  2008cited by this paper
• Occurrence, fate and assessment of polar metamizole (dipyrone) residues in hospital and municipal wastewater.

  2008cited by this paper
• Removal of pharmaceuticals and kinetics of mineralization by O(3)/H(2)O(2) in a biotreated municipal wastewater.

  2008cited by this paper
• Oxidation of N-nitrosodimethylamine (NDMA) precursors with ozone and chlorine dioxide: kinetics and effect on NDMA formation potential.

  2007cited by this paper
• Bezafibrate removal by means of ozonation: primary intermediates, kinetics, and toxicity assessment.

  2007cited by this paper
• Ultimate biodegradation and elimination of antibiotics in inherent tests.

  2007cited by this paper
• Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme.

  2006cited by this paper
• Ozone Oxidation of Endocrine Disruptors and Pharmaceuticals in Surface Water and Wastewater

  2006cited by this paper
• Genotoxic potential of by-products in drinking water in relation to water disinfection: survey of pre-ozonated and post-chlorinated drinking water by Ames-test.

  2006cited by this paper
• Ozonation of carbamazepine in drinking water: identification and kinetic study of major oxidation products.

  2005cited by this paper
• A new approach to evaluating the toxicity and genotoxicity of disinfected drinking water.

  2004cited by this paper
• Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?

  2003cited by this paper
• Oxidation of pharmaceuticals during ozonation and advanced oxidation processes.

  2003cited by this paper
• Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance.

  2002cited by this paper
• Changes in mutagenicity during biodegradation of fenitrothion.

  2002cited by this paper
• S9 induction by the combined treatment with cyclohexanol and albendazole.

  2001cited by this paper
• Statistical methods for the Ames Salmonella assay: a review.

  1999cited by this paper
• OECD GUIDELINE FOR TESTING OF CHEMICALS

  1998cited by this paper
• Induction of chromosomal damage in mammalian cells in vitro and in vivo by sulfapyridine or 5-aminosalicylic acid.

  1992cited by this paper
• Mutagenicity of the components of ozonated humic substance.

  1991cited by this paper
• Disinfectants and disinfectant by-products

  1987cited by this paper
• Importance of sample pH on recovery of mutagenicity from drinking water by XAD resins.

  1987cited by this paper
• Revised methods for the Salmonella mutagenicity test.

  1983cited by this paper

• Ecotoxicological assessment of metformin as an antidiabetic water residue treated by electron beam accelerator irradiation

  2024influential citation
• Co-occurrence, toxicity, and biotransformation pathways of metformin and its intermediate product guanylurea: Current state and future prospects for enhanced biodegradation strategy.

  2024cites this paper
• Prediction of metformin adsorption on subsurface sediments based on quantitative experiment and artificial neural network modeling.

  2023cites this paper
• Bioconcentration and cellular effects of emerging contaminants in sponges from Maldivian coral reefs: A managing tool for sustainable tourism.

  2023cites this paper
• Anaerobic Biodegradation of Dipyrone: Determination of Transformation Products by LC-HRMS and Ecotoxicity Assessment using Target Organisms and QSAR Model

  2022cites this paper
• Metformin as an emerging concern in wastewater: Occurrence, analysis and treatment methods.

  2022cites this paper
• Ensaios toxicológicos aplicados à análise de águas contaminadas por fármacos

  2020cites this paper
• Environmental risk assessment of metformin and its transformation product guanylurea. I. Environmental fate.

  2019cites this paper
• Nootropic drugs: Methylphenidate, modafinil and piracetam - Population use trends, occurrence in the environment, ecotoxicity and removal methods - A review.

  2019cites this paper
• Spatial and Temporal Variability in Attenuation of Polar Organic Micropollutants in an Urban Lowland Stream.

  2019cites this paper
• Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages

  2018cites this paper
• Isolation of two Ochrobactrum sp. strains capable of degrading the nootropic drug-Piracetam.

  2017cites this paper
• Consumption-based approach for pharmaceutical compounds in a large hospital

  2017cites this paper
• A global perspective on the use, occurrence, fate and effects of anti-diabetic drug metformin in natural and engineered ecosystems.

  2016cites this paper
• Hospital and Municipal Wastewater: Identification of Relevant Pharmaceutical Compounds

  2016cites this paper
• Investigations on sediment toxicity of German rivers applying a standardized bioassay battery

  2015cites this paper
• Comprehensive study of the antidiabetic drug metformin and its transformation product guanylurea in Greek wastewaters.

  2015cites this paper
• Characterization, DBPs formation, and mutagenicity of soluble microbial products (SMPs) in wastewater under simulated stressful conditions

  2015cites this paper
• Characterization, DBPs formation, and mutagenicity of different organic matter fractions in two source waters.

  2014cites this paper
• Occurrence of the antidiabetic drug Metformin and its ultimate transformation product Guanylurea in several compartments of the aquatic cycle.

  2014cites this paper
• Environmental risk assessment of anti-cancer drugs and their transformation products: A focus on their genotoxicity characterization-state of knowledge and short comings.

  2014cites this paper
• Mimicking the intramolecular hydrogen bond: synthesis, biological evaluation, and molecular modeling of benzoxazines and quinazolines as potential antimalarial agents.

  2012cites this paper
• Occurrence and fate of the antidiabetic drug metformin and its metabolite guanylurea in the environment and during drinking water treatment.

  2012cites this paper
• Incomplete aerobic degradation of the antidiabetic drug Metformin and identification of the bacterial dead-end transformation product Guanylurea.

  2011cites this paper